"Aterogenn\u00ED potenci\u00E1l poruch metabolismu mastn\u00FDch kyselin a cholesterolu v procesu koron\u00E1rn\u00ED aterogeneze u diabetu mellitu II.typu." . . . . "saturated fatty acids" . . . "diabetes mellitus type II" . "2005-07-18+02:00"^^ . . "atherosclerosis;diabetes mellitus type II;saturated fatty acids;polyunsaturated fatty acids;CAD;lipoperoxidation;vitamin E;dyslipidaemia"@en . "lipoperoxidation" . . . "21"^^ . "http://www.isvav.cz/projectDetail.do?rowId=NB6999"^^ . . "21"^^ . "The results of the project support that the level of lipoperoxidation by patientes with ICHS doesn\u00B4t associate with the relevance of coronary finding."@en . "Prospective clinical study of the mutual interactions and particular role of phenotype and genotype of dysliproproteinaemia in atherogenesis of coronary heart disease in patients with diabetes mellitus type II to investigate correlation of occurrence and the grade of coronary atherosclerosis with the selected parameters. Annot.II: Parameters monitored will be:i) serum lipids and lipoproteins, ii) vitamin E in serum and lipoproteins, iii) plasma and cell membrane structure of unsaturated and saturated fatty acids, iv) lipoperoxidation formation and antioxidant consumption, v) metabolites of cholesterol synthesis."@en . . "CAD" . . . . "atherosclerosis" . "Atherogenic role of disorders of fatty acid and cholesterol metabolism in coronary atherogenesis in diabetes mellitus type II."@en . "vitamin E" . "Prospektivn\u00ED klinick\u00E1 studie vz\u00E1jemn\u00E9 vazby a \u00FAlohy fenotypu a genotypu dyslipoprotein\u00E9mi\u00ED v procesu aterogeneze u pacient\u016F s ischemickou chorobou srde\u010Dn\u00ED, dyslipid\u00E9mi\u00ED a diabetem mellitem II.typu., s c\u00EDlem posoudit korelaci v\u00FDskytu a z\u00E1va\u017Enosti event. koron\u00E1rn\u00ED aterosklerosy u t\u011Bchto nemocn\u00FDch s n\u00ED\u017Ee uveden\u00FDmi parametry. Anotac.II - Sledovan\u00E9 parametry jsou:i) spektrum lip\u016F v s\u00E9ru a ve vrstv\u00E1ch lipoprotein\u016F, ii) obsah vitaminu E v s\u00E9ru a ve vrstv\u00E1ch lipoprotein\u016F, iii) plasmatick\u00E9 a membr\u00E1nov\u00E9 slo\u017Een\u00ED nenasycen\u00FDch a nasycen\u00FDch mastn\u00FDch kyselin, iv) antioxida\u010Dn\u00ED profil, v) metabolity sytn\u00E9zy cholesterolu." . . . . "0"^^ . . . "polyunsaturated fatty acids" . "1"^^ . "V\u00FDsledky dokl\u00E1daj\u00ED, \u017Ee \u00FArove\u0148 lipoperoxidace u pacient\u016F s ICHS nen\u00ED asociov\u00E1na se z\u00E1va\u017Enost\u00ED koronarografick\u00E9ho n\u00E1lezu."@cs . . "0"^^ . "NB6999" . .